BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 663586)

  • 1. [Anti-tumor antibodies in the blood of patients with gliomas].
    Martin-Achard A; Diserens AC; de Tribolet N; Zander E; Carrel S
    Schweiz Med Wochenschr; 1978 Jun; 108(25):959-62. PubMed ID: 663586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface antigenic characteristics of human glial brain tumor cells.
    Wikstrand CJ; Mahaley MS; Bigner DD
    Cancer Res; 1977 Dec; 37(12):4267-75. PubMed ID: 72598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human glioma-associated antigens detected by monoclonal antibodies.
    Schnegg JF; Diserens AC; Carrel S; Accolla RS; de Tribolet N
    Cancer Res; 1981 Mar; 41(3):1209-13. PubMed ID: 7459861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunofluorescence microscopy of a malignant glioma with regard to the occurrence and significance of glioma specific antibodies].
    Hackenberg P; Koschnike P
    Psychiatr Neurol Med Psychol (Leipz); 1980 Apr; 32(4):206-13. PubMed ID: 7413856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the humoral response of glioma patients to a possible common tumor-associated antigen(s).
    Martin-Achard A; Diserens AC; de Tribolet N; Carrel S
    Int J Cancer; 1980 Feb; 25(2):219-24. PubMed ID: 7390650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of serum antibody reactivity to autologous head and neck cancer cell lines and augmentation of antibody reactivity following acid dissociation and ultrafiltration.
    Vlock DR; Scalise D; Schwartz DR; Richter DE; Krause CJ; Baker SR; Carey TE
    Cancer Res; 1989 Mar; 49(6):1361-5. PubMed ID: 2924293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytotoxic natural anti-tumor antibodies against fibrosarcoma and glioma cells in rats (author's transl)].
    Itaya T
    Hokkaido Igaku Zasshi; 1981 Sep; 56(5):499-506. PubMed ID: 7319460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors.
    de Muralt B; de Tribolet N; Diserens AC; Carrel S; Mach JP
    Anticancer Res; 1983; 3(1):1-6. PubMed ID: 6830147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the antibody-dependent cellular cytotoxicity test to detect antibodies in sera of breast cancer patients.
    Plain MJ; Whitehead RH; Jose DG
    J Natl Cancer Inst; 1981 Apr; 66(4):619-24. PubMed ID: 7014964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic analysis of nitrosourea-induced rat gliomas.
    Pfreundschuh M; Cravioto H; Hochwald G; Ransohoff J
    J Natl Cancer Inst; 1982 Mar; 68(3):501-5. PubMed ID: 6950179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and immunological significance of human melanoma cytotoxic antibody.
    Bodurtha AJ; Chee DO; Laucius JF; Mastrangelo MJ; Prehn RT
    Cancer Res; 1975 Jan; 35(1):189-93. PubMed ID: 1109788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated cytotoxicity and serum-mediated blocking: evidence that their associated determinants on human tumor cells are different.
    Levy NL
    J Immunol; 1978 Sep; 121(3):916-22. PubMed ID: 80433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor markers of the central nervous system.
    Birkmayer GD
    Cancer Detect Prev; 1981; 4(1-4):231-8. PubMed ID: 7349780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
    Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
    Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the heterogeneity of anti-tumor antibody responses.
    Segal GP; Klinman NR
    J Immunol; 1976 Jun; 116(6):1539-46. PubMed ID: 58038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a human glioma antigen, SOX6, recognized by patients' sera.
    Ueda R; Iizuka Y; Yoshida K; Kawase T; Kawakami Y; Toda M
    Oncogene; 2004 Feb; 23(7):1420-7. PubMed ID: 14691456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent cell-mediated cytolysis of human colon carcinoma cells induced by specific antisera against carcinoembryonic antigen.
    Carrel S; Delisle MC; Mach JP
    Cancer Res; 1977 Aug; 37(8 Pt 1):2644-50. PubMed ID: 872092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-class II antibodies in AIDS patients and AIDS-risk groups.
    de la Barrera S; Fainboim L; Lugo S; Picchio GR; Muchinik GR; de Bracco MM
    Immunology; 1987 Dec; 62(4):599-604. PubMed ID: 3501399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine monoclonal antibodies cytotoxic to human glioma cells in vitro.
    Sánchez-Gómez MV; Conde-Guerri B; Sinués-Porta E; Matute C
    Histol Histopathol; 1992 Oct; 7(4):619-24. PubMed ID: 1457984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.